ALKS vs EXPE · P/E 14, rev $1.56B vs P/E 20, rev $13.69B
Alkermes Plc (ALKS) versus Expedia Group Inc. (EXPE) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Expedia Group Inc. (EXPE) is a travel services company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported EXPE revenue for 2024-12-31 was $13.69B. Net income was $1.22B. Revenue was up 6.6% from 2023-12-31 to 2024-12-31. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
Not investment advice. Open the ALKS and EXPE stock pages for the full models.
Not investment advice.